Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.47 |
| ▸ | POLB | P06746 | 1/20 | 0.47 |
| ▸ | CCNE2 | O96020 | 1/20 | 0.38 |
| ▸ | CCNE1 | P24864 | 1/20 | 0.38 |
| ▸ | CDK2 | P24941 | 1/20 | 0.38 |
| ▸ | NPC1 | O15118 | 1/20 | 0.36 |
| ▸ | LRRK2 | Q5S007 | 2/20 | 0.36 |
| ▸ | GPBAR1 | Q8TDU6 | 1/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.35 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.35 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.34 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.34 |
| ▸ | DYRK1A | Q13627 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4121669 | 0.77 | CCNE2 (0.36) | KDM4EALDH1A1CCNE2CCNE1CDK2 | |
| SCHEMBL6270187 | 0.75 | CCNE2 (0.41) | KDM4ECCNE2CCNE1CDK2NPC1 | |
| SCHEMBL7877997 | 0.75 | TDP1 (0.44) | KDM4ECCNE2CCNE1CDK2NPC1 | |
| SCHEMBL4115203 | 0.72 | BTK (0.45) | NPC1 | |
| SCHEMBL3038641 | 0.72 | CES2 (0.46) | CCNE2CCNE1CDK2NPC1HSD11B1 | |
| SCHEMBL30103582 | 0.71 | CCNE2 (0.37) | KDM4ECCNE2CCNE1CDK2NPC1 | |
| SCHEMBL29985757 | 0.70 | CNR2 (0.36) | KDM4ECCNE2CCNE1CDK2NPC1 | |
| SCHEMBL5914464 | 0.69 | KDM4E (0.46) | KDM4EALDH1A1POLBCYP1A2CYP3A4 | |
| SCHEMBL11356632 | 0.69 | KDM4E (0.54) | KDM4EALDH1A1POLBNPC1HSD17B10 | |
| SCHEMBL14715801 | 0.69 | KDM4E (0.47) | KDM4EALDH1A1POLBCYP1A2CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090111989-A1 | ORGANIC LIGHT EMITTING MATERIALS WITH ANIONIC LIGAND | THOMPSON MARK E | 2009-04-30 | — | — | US | disclosed |
| US-7482451-B2 | Organic light emitting materials with anionic ligand | THE UNIVERSITY OF SOUTHERN CALIFORNIA (US) | 2009-01-27 | — | — | US | disclosed |
| EP-1539773-A2 | ORGANIC LIGHT EMITTING MATERIALS WITH ANIONIC LIGAND | UNIVERSITY OF SOUTHERN CALIFORNIA (US) | 2005-06-15 | — | — | EP | disclosed |
| US-20040102632-A1 | Organic light emitting materials with anionic ligand | UNIVERSITY OF SOUTHERN CALIFORNIA, THE | 2004-05-27 | — | — | US | disclosed |
| WO-2004017043-A2 | ORGANIC LIGHT EMITTING MATERIALS WITH ANIONIC LIGAND | THE UNIVERSITY OF SOUTHERN CALIFORNIA (US) | 2004-02-26 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090111989-A1 | ORGANIC LIGHT EMITTING MATERIALS WITH ANIONIC LIGAND | MAP1LC3C, ORC3, EML4 | KDM4E 3502/4885ALDH1A1 1050/4885POLB 4092/4885 |
| US-20040102632-A1 | Organic light emitting materials with anionic ligand | MAP1LC3C, ORC3, EML4 | KDM4E 3502/4885ALDH1A1 1050/4885POLB 4092/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.